Adaptive Biotechnologies posted strong Q3 results, beating expectations and reducing losses, while management has done a good job of reducing quarterly cash burn rates. The company's MRD segment, ...

Adaptive Biotechnologies Corp (ADPT) reported its fourth-quarter 2025 earnings, surpassing analyst expectations with a significant earnings and revenue beat. The company posted an EPS of -$0.09 ...

Investing.com -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT) shares surged 6.3% in after-hours trading Thursday after the company reported fourth-quarter results that significantly exceeded ...

In the last three months, 4 analysts have published ratings on Adaptive Biotechnologies (NASDAQ:ADPT), offering a diverse range of perspectives from bullish to bearish. The table below provides a ...